These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8429536)

  • 1. Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases.
    Payne DJ; Amyes SG
    J Med Microbiol; 1993 Feb; 38(2):114-7. PubMed ID: 8429536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cefdinir with beta-lactamases.
    Labia R; Morand A
    Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of clinical bacteria isolated in Scotland to the oral cephalosporin, cefdinir.
    Payne DJ; Amyes SG
    Drugs Exp Clin Res; 1992; 18(6):225-31. PubMed ID: 1478161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
    Wise R; Andrews JM; Thornber D
    J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of 5 beta-lactam antibiotics to beta-lactamase isolated from E. coli and its respective transconjugates].
    Galante D; Esposito S; Barba D; Scioli C
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1678-82. PubMed ID: 6320847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens.
    Kunugita C; Higashitani F; Hyodo A; Unemi N; Inoue M
    J Antibiot (Tokyo); 1995 Dec; 48(12):1453-9. PubMed ID: 8557603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
    Queenan AM; Shang W; Kania M; Page MG; Bush K
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3089-95. PubMed ID: 17591851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.
    Matsumoto Y; Ikeda F; Kamimura T; Yokota Y; Mine Y
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1243-6. PubMed ID: 3056257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes.
    Prinarakis EE; Tzouvelekis LS; Legakis NJ
    Chemotherapy; 1998; 44(4):260-4. PubMed ID: 9681202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
    Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
    Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
    Walther-Rasmussen J; Høiby N
    Can J Microbiol; 2004 Mar; 50(3):137-65. PubMed ID: 15105882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir: in vitro activity study and effect of human serum.
    García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
    Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.
    Bellais S; Poirel L; Fortineau N; Decousser JW; Nordmann P
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2965-8. PubMed ID: 11557504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot J; Sirot D; Petit A
    Rev Infect Dis; 1988; 10(4):885-91. PubMed ID: 3055180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence.
    Schumacher H; Skibsted U; Skov R; Scheibel J
    APMIS; 1996; 104(7-8):531-8. PubMed ID: 8920806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.